Valuation : North China Pharmaceutical Company.Ltd

Market Cap 8.48B 1.26B 1.09B 1.03B 934M 1.75B 121B 1.76B 12.24B 4.71B 61.41B 4.74B 4.64B 194B P/E 2024
69.9x
P/E 2025 51.7x
Enterprise Value 18.15B 2.71B 2.33B 2.21B 2B 3.75B 258B 3.77B 26.21B 10.08B 131B 10.16B 9.94B 416B EV / Sales 2024
1.89x
EV / Sales 2025 2.07x
Free-Float
40.58%
Yield 2024
0.58%
Yield 2025 0.63%
1 day-4.63%
1 week+5.33%
Current month+3.13%
1 month-1.40%
3 months+10.27%
6 months-14.83%
Current year-10.67%
1 week 4.67
Extreme 4.67
5.28
1 month 4.56
Extreme 4.56
5.28
Current year 4.11
Extreme 4.11
6.07
1 year 4.11
Extreme 4.11
6.29
3 years 3.83
Extreme 3.83
7.46
5 years 3.83
Extreme 3.83
13.45
10 years 3.83
Extreme 3.83
20.24
Manager TitleAgeSince
Chief Executive Officer 55 27/11/2025
Director of Finance/CFO 46 09/04/2024
Investor Relations Contact 45 -
Director TitleAgeSince
Chairman 49 21/03/2016
Director/Board Member 53 22/04/2021
Director/Board Member 54 11/10/2022
Date Insider Type Main position Quantity % Market Cap. Importance
25/02/25 Buy

Chairman

1,600 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-4.63%+5.33%-18.08%-10.02% 1.26B
-0.65%-2.93%+47.70%+86.17% 994B
-0.29%-3.51%+49.15%+62.35% 640B
+0.83%+0.26%+17.76%+72.25% 454B
-0.38%-3.59%+30.13%+35.17% 337B
-0.09%-13.54%+13.34%+24.95% 261B
-0.43%-2.48%-0.73%+9.58% 246B
-1.34%-13.70%+36.53%+44.96% 204B
-3.44%-7.51%-20.63%-59.44% 190B
-0.75%-4.82%+25.46%+87.14% 178B
Average -1.12%-4.69%+18.06%+35.31% 350.6B
Weighted average by Cap. -0.51%-4.41%+30.94%+54.92%

Financials

2024 2025
Net sales 9.87B 1.47B 1.27B 1.2B 1.09B 2.04B 141B 2.05B 14.25B 5.48B 71.5B 5.53B 5.4B 226B 9.24B 1.38B 1.19B 1.12B 1.02B 1.91B 132B 1.92B 13.35B 5.13B 66.96B 5.17B 5.06B 212B
Net income 127M 18.93M 16.31M 15.44M 14M 26.26M 1.81B 26.39M 183M 70.53M 920M 71.09M 69.53M 2.91B 183M 27.29M 23.51M 22.26M 20.18M 37.85M 2.61B 38.05M 264M 102M 1.33B 102M 100M 4.19B
Net Debt 9.79B 1.46B 1.26B 1.19B 1.08B 2.02B 139B 2.03B 14.14B 5.44B 70.93B 5.48B 5.36B 224B 9.67B 1.44B 1.24B 1.18B 1.07B 2B 138B 2.01B 13.97B 5.37B 70.09B 5.42B 5.3B 221B
Logo North China Pharmaceutical Company.Ltd
North China Pharmaceutical Co Ltd is a China-based company primarily engaged in the research, development, production and sales of pharmaceutical products. The Company's main products include anti-infective drugs, nephrology and immunomodulatory drugs, biotechnology drugs, cardiovascular and cerebrovascular and immunomodulatory agents, vitamins and health consumer products, nervous and blood system drugs, pharmaceutical intermediates, anti-epidemic drugs, pesticides and Veterinary drugs. The Company is also engaged in pharmaceutical and other logistics trade pharmaceuticals. The Company's products are mainly used in chemical pharmaceuticals, modern biotechnology drugs, vitamins and health consumer products, bioagricultural and veterinary drugs and other fields. The Company mainly conducts its businesses in domestic and overseas markets.
Employees
9,972
Date Price Change Volume
11/09/26 CN¥4.940 -4.63% 105,335,050
10/09/26 CN¥5.180 +7.92% 112,742,043
09/09/26 CN¥4.800 -1.44% 14,744,354
08/09/26 CN¥4.870 +3.40% 21,116,513
07/09/26 CN¥4.710 +0.43% 7,565,700

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600812 Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!